Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v21-FR Version v13-FR
Language French French
Date Updated 2020-05-22 2018-11-13
Drug Identification Number 02448750 02448750
Brand name AURO-OLANZAPINE ODT AURO-OLANZAPINE ODT
Common or Proper name OLANZAPINE OLANZAPINE
Company Name AURO PHARMA INC AURO PHARMA INC
Ingredients OLANZAPINE OLANZAPINE
Strength(s) 20MG 20MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 3X10 3X10
ATC code N05AH N05AH
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-07-25 2018-07-25
Estimated end date 2020-09-15 Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Company comments
Health Canada comments